비씨월드제약 반기보고서 (2022.06)
1. 요약재무정보

당사는 주식회사의 외부감사에 관한법률 제13조 1항1호에서 규정하고 있는 국제회계기준위원회의 국제회계기준을 채택하여 정한 회계처리기준인 한국채택국제회계기준에 따라 재무제표를 작성하였습니다. 가. 연결요약재무정보

(단위 : 원)

과목	제43(당)반기	제42(전)기	제41(전전)기

2022년 6월말	2021년 12월말	2020년 12월말

[유동자산]	41,252,296,297	37,234,632,805	43,063,353,911

ㆍ당좌자산	3,540,347,644	4,502,521,874	12,560,812,998

ㆍ매출채권및기타매출	17,866,521,391	15,926,836,566	14,712,393,488

ㆍ재고자산	19,396,526,021	16,147,338,543	15,369,696,704

ㆍ기타유동자산	448,901,241	657,935,822	420,450,721

[비유동자산]	148,034,729,499	147,866,196,108	133,861,893,309

ㆍ투자자산	3,024,804,157	3,756,414,963	3,302,572,873

ㆍ유형자산	138,692,746,240	138,364,625,901	125,499,562,540

ㆍ무형자산	2,829,641,522	2,265,766,219	1,174,791,740

ㆍ기타비유동자산	3,487,537,580	3,479,389,025	3,884,966,156

자산총계	189,287,025,796	185,100,828,913	176,925,247,220

[유동부채]	72,505,651,041	57,092,474,507	56,159,648,971

[비유동부채]	36,847,703,851	47,118,639,804	37,197,777,228

부채총계	109,353,354,892	104,211,114,311	93,357,426,199

[지배기업지분]	81,660,948,232	82,252,930,454	84,161,106,151

ㆍ자본금	1,778,476,800	1,778,476,800	1,778,476,800

ㆍ자본잉여금	34,947,264,726	34,947,264,726	34,947,264,726

ㆍ자본조정	(771,621,170)	(771,621,170)	(771,621,170)

ㆍ기타포괄손익누계	(30,288,581)	248,541,317	100,654,351

ㆍ이익잉여금	45,737,116,457	46,050,268,781	48,106,331,444

[소수주주지분]	(1,727,277,328)	(1,363,215,852)	(593,285,130)

자본총계	79,933,670,904	80,889,714,602	83,567,821,021

구분	(2022.01.01 ~2022.06.30)	(2021.01.01 ~2021.12.31)	(2020.01.01 ~2020.12.31)

매출액	34,403,923,957	62,079,356,724	57,030,365,933

영업이익	914,345,315	(1,798,448,805)	(2,096,430,277)

당기순이익	476,544,984	(2,248,277,905)	(2,194,132,936)

ㆍ지배회사지분순손익	840,606,461	(1,478,347,183)	(1,579,980,801)

ㆍ소수주주지분순손익	(364,061,477)	(769,930,722)	(614,152,135)

총포괄손익	(102,187,198)	(1,824,249,922)	(1,606,753,189)

ㆍ지배회사지분순손익	261,874,279	(1,054,319,200)	(992,601,054)

ㆍ소수주주지분순손익	(364,061,477)	(769,930,722)	(614,152,135)

주당순이익(원)	98	(173)	(186)

1	1	1

나. 별도요약재무정보(단위 : 원)

과목	제43(당)반기	제42(전)기	제41(전전)기

2022년 6월말	2021년 12월말	2020년 12월말

[유동자산]	39,307,967,266	38,323,993,872	44,300,496,258

ㆍ당좌자산	3,481,842,729	4,306,087,488	11,180,509,978

ㆍ매출채권및기타매출	17,612,181,762	19,695,344,344	21,456,453,487

ㆍ재고자산	14,793,557,493	13,819,373,505	11,475,965,608

ㆍ기타유동자산	3,420,385,282	503,188,535	187,567,185

[비유동자산]	115,997,977,093	115,237,474,070	100,701,015,034

ㆍ투자자산	3,024,804,157	3,756,414,963	3,302,572,873

ㆍ유형자산	108,630,899,665	107,751,068,428	94,021,043,850

ㆍ무형자산	2,667,809,159	2,077,095,551	1,017,857,740

ㆍ기타비유동자산	1,674,464,112	1,652,895,128	2,359,540,571

자산총계	155,305,944,359	153,561,467,942	145,001,511,292

[유동부채]	49,572,194,038	38,501,443,240	38,224,757,642

[비유동부채]	22,377,703,851	31,443,872,944	22,022,359,996

부채총계	71,949,897,889	69,945,316,184	60,247,117,638

ㆍ자본금	1,778,476,800	1,778,476,800	1,778,476,800

ㆍ자본잉여금	34,947,264,726	34,947,264,726	34,947,264,726

ㆍ자본조정	(771,621,170)	(771,621,170)	(771,621,170)

ㆍ기타포괄손익누계	(30,288,581)	248,541,317	100,654,351

ㆍ이익잉여금	47,432,214,695	47,413,490,085	48,699,618,947

자본총계	83,356,046,470	83,616,151,758	84,754,393,654

종속ㆍ관계ㆍ공동기업투자주식의 평가방법	지분법	지분법	지분법

구분	(2022.01.01 ~2022.06.30)	(2021.01.01 ~2021.12.31)	(2020.01.01 ~2020.12.31)

매출액	32,166,931,357	60,847,744,038	57,425,317,939

영업이익	1,538,067,272	413,955,283	(410,058,272)

당기순이익	1,172,483,394	(708,413,382)	(986,693,298)

기타포괄손익	(578,732,182)	424,027,983	587,379,747

ㆍ재분류되지 않는 손익	(578,732,182)	424,027,983	587,379,747

총포괄손익	593,751,212	(284,385,399)	(399,313,551)

주당순이익(원)	137	(83)	(116)